Robot-Assisted Simple Prostatectomy: A Comparison of Primary Simple Prostatectomy <i>vs</i> Salvage Simple Prostatectomy in Treatment of Lower Urinary Tract Symptoms

Pathak, R. S.; Krol, Bridget; Crain, Nikhil; Hemal, Ashok K.

doi:10.1089/end.2022.0588

Cited by 3 publications

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With increasing familiarity and advances in robotic surgical systems along with its expansion to a variety of disease processes, RASP is gradually replacing the open approach due to improved peri-operative and functional outcomes [18][19][20] [7,21]. In our analysis, the median blood loss was found to be 150 cc for the entire population which was similar between the two groups (150 cc vs 150 cc, p = 0.38).…”

Section: Discussionmentioning

confidence: 65%

Safety and Complications of Continuation of Aspirin Therapy in Patients Undergoing Robot-Assisted Laparoscopic Simple Prostatectomy

Saini,

Thakker,

Ritts

et al. 2024

Preprint

View full text Add to dashboard Cite

Objective To evaluate the safety and feasibility of continued perioperative aspirin at the time of robotic assisted simple prostatectomy (RASP). Materials and Methods We performed a retrospective review of our IRB approved institutional database of patients who underwent RASP between 2013 to 2022. Comparative groups included patients taking aspirin continued in the perioperative period and those not taking aspirin pre-operatively. The primary outcome was any post-operative bleeding related complication using the modified Clavien-Dindo classification. Secondary outcomes included the identification of risk factors for increased blood loss in the entire study population, operative time, and blood transfusion requirement. Results 143 patients underwent RASP of which 55 (38.5%) patients had continued perioperative aspirin therapy and 88 (61.5%) patients did not take perioperative aspirin. Baseline demographics were similar between the groups. Patients taking perioperative aspirin had a higher rate of hypertension (74.5% vs 58.0%, p = 0.04) and other cardiovascular disease (30.9% vs 11.4%, p = 0.007). Postoperative complications were similar between the groups (Clavien Dindo ³ 3; p = 0.43). Median blood loss (150 cc vs 150 cc, p = 0.38), percentage drop in hemoglobin (13.4 vs 13.2, p = 0.94) and blood transfusion rate (3.6 vs 1.1, p = 0.56) were similar between the two groups. The median blood loss was 150 ml for the whole study population. On regression analysis, neither aspirin nor any other variable was associated with increased blood loss (> 150 ml). Conclusions Aspirin can be safely continued perioperatively in patients undergoing RASP without any risk of bleeding related complications, blood loss, or increased transfusion rate.

show abstract

Section: Discussionmentioning

confidence: 65%

Safety and Complications of Continuation of Aspirin Therapy in Patients Undergoing Robot-Assisted Laparoscopic Simple Prostatectomy

Saini,

Thakker,

Ritts

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

Safety and complications of continuation of aspirin therapy in patients undergoing robot-assisted laparoscopic simple prostatectomy

Saini,

Thakker,

Ritts

et al. 2024

J Robotic Surg

View full text Add to dashboard Cite

To evaluate the safety and feasibility of continued perioperative aspirin at the time of robotic assisted simple prostatectomy (RASP). We performed a retrospective review of our IRB approved institutional database of patients who underwent RASP between 2013 and 2022. Comparative groups included patients taking aspirin in the perioperative period and those not taking aspirin pre-operatively. The primary outcome was any post-operative bleeding related complication using the modified Clavien–Dindo classification. Secondary outcomes included the identification of risk factors for increased blood loss in the entire study population, operative time, and blood transfusion requirement. 143 patients underwent RASP of which 55 (38.5%) patients continued perioperative aspirin therapy and 88 (61.5%) patients did not. Baseline demographics were similar between groups. Patients taking perioperative aspirin had a higher rate of hypertension (74.5% vs 58.0%, p = 0.04) and other cardiovascular disease (30.9% vs 11.4%, p = 0.007). Postoperative complications were similar between the groups (Clavien-Dindo ≥ 3; p = 0.43). Median blood loss (150 cc vs 150 cc, p = 0.38), percentage drop in hemoglobin (13.4 vs 13.2, p = 0.94) and blood transfusion rate (3.6 vs 1.1, p = 0.56) were also similar between groups. The median blood loss was 150 ml for the whole study population. On regression analysis, neither aspirin nor any other variable was associated with increased blood loss (> 150 ml). Aspirin can be safely continued perioperatively in patients undergoing RASP without any risk of bleeding related complications, blood loss, or increased transfusion rate.

show abstract

Comment on: “Initial Postoperative Prostate Specific Antigen and PSA Velocity Are Important Indicators of Underlying Malignancy After Simple Prostatectomy” by Livingston et al.

Lopategui,

Porto,

Bhatia

et al. 2024

Journal of Endourology

View full text Add to dashboard Cite

Robot-Assisted Simple Prostatectomy: A Comparison of Primary Simple Prostatectomy vs Salvage Simple Prostatectomy in Treatment of Lower Urinary Tract Symptoms

Cited by 3 publications

References 18 publications

Safety and Complications of Continuation of Aspirin Therapy in Patients Undergoing Robot-Assisted Laparoscopic Simple Prostatectomy

Safety and Complications of Continuation of Aspirin Therapy in Patients Undergoing Robot-Assisted Laparoscopic Simple Prostatectomy

Safety and complications of continuation of aspirin therapy in patients undergoing robot-assisted laparoscopic simple prostatectomy

Comment on: “Initial Postoperative Prostate Specific Antigen and PSA Velocity Are Important Indicators of Underlying Malignancy After Simple Prostatectomy” by Livingston et al.

Contact Info

Product

Resources

About